Related Experiment Video
Updated: Jan 16, 2026
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.9K
Changes in pharmaceutical industry payments to physicians after New Jersey's 2018 restriction
Neeraj G Patel1, Reshma Ramachandran2,3, Joseph S Ross2,3,4
1Yale School of Medicine, New Haven, CT 06510, United States.
Health Affairs Scholar
|January 15, 2026
Summary
New Jersey
Area of Science:
- Health Policy
- Pharmaceutical Industry
- Medical Economics
Background:
- Government and state policies aim to regulate pharmaceutical industry payments to clinicians.
- New Jersey implemented a $10,000 cap on annual prescriber compensation in 2018.
- Transparency and restrictions on payments seek to influence prescribing practices.
Purpose of the Study:
- To evaluate the impact of New Jersey's payment restriction policy.
- To compare payment trends between New Jersey and a control state (Pennsylvania).
- To assess changes in physicians receiving high aggregate compensation.
Main Methods:
- Quasi-experimental design comparing New Jersey and Pennsylvania.
- Analysis of prescriber payment data before and after policy implementation.
- Statistical comparison of physicians exceeding the $10,000 compensation threshold.
Main Results:
- No significant difference observed in the proportion of physicians exceeding $10,000 in annual payments in New Jersey compared to Pennsylvania.
- The policy did not significantly alter the distribution of high-paying compensation arrangements for physicians.
- The restriction's effectiveness in reducing aggregate payments needs further investigation.
Conclusions:
- The New Jersey policy capping prescriber compensation did not show a significant impact compared to Pennsylvania.
- Further research is required to understand the broader effects of state-level policies on pharmaceutical industry payments.
- Investigating alternative policy designs or enforcement mechanisms may be necessary.
Related Concept Videos
01:26FDA Approved Drugs: Changes to Approved Drugs
242
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
242
01:28Drug Products: Biologics, Biosimilars and Interchangeables
233
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
233
01:29Issues And Trends In Healthcare Delivery System
6.1K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.1K
01:02Prescription, Nonprescription and Orphan Drugs
1.2K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.2K
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
178
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
178
01:26Pharmaceutical Equivalents
182
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
182